SOLID PHARMACEUTICAL PREPARATION

摘要

Solid pharmaceutical preparations comprising an insulin resistance ameliorant and an HMG-CoA reductase inhibitor wherein the stability of these agents is not deteriorated. In particular, solid pharmaceutical preparations comprising granules containing an insulin resistance ameliorant and granules containing an HMG-CoA reductase inhibitor.